Aurinia Pharmaceuticals
AUPH
#5412
Rank
€0.92 B
Marketcap
6,50 €
Share price
0.00%
Change (1 day)
-16.93%
Change (1 year)

EPS for Aurinia Pharmaceuticals (AUPH)

EPS in 2023 (TTM): -0,49 €

According to Aurinia Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -0,48 €. In 2022 the company made an earnings per share (EPS) of -0,69 € an increase over its 2021 EPS that were of -1,27 €.

EPS history for Aurinia Pharmaceuticals from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,49 €-28.29%
2022-0,69 €-46.1%
2021-1,27 €63.95%
2020-0,78 €-33.85%
2019-1,17 €73.33%
2018-0,68 €-34.78%
2017-1,04 €74.24%
2016-0,60 €13.79%
2015-0,52 €-15.94%
2014-0,62 €61.51%
2013-0,39 €-83.03%
2012-2,27 €621.77%
2011-0,31 €-75.81%
2010-1,30 €-53.29%
2009-2,79 €-59.15%
2008-6,82 €-50.57%
2007-13,80 €16.07%
2006-11,89 €-28.86%
2005-16,71 €25.38%
2004-13,33 €51.08%
2003-8,82 €4032.42%
2002-0,21 €
2000-7,93 €318.35%
1999-1,90 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
33,71 €-7,149.06%🇺🇸 USA
-4,21 € 779.25%🇺🇸 USA
-0,33 €-30.19%🇺🇸 USA